Upcoming Events

Year: 2022

Latest news

IIBB researches identify JAK2 as a novel target for the treatment of liver fibrosis

A study recently published in Hepatology describes a new inhibitor of the JAK2 protein, Pacritinib, as a potential treatment for alcoholic and non-alcoholic liver fibrosis. The study led by Professor Jonel Trebicka of the University of Münster, and Dr.

Read More